Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009360
Filing Date
2019-05-10
Accepted
2019-05-10 07:36:23
Documents
44
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20190331_10q.htm 10-Q 558813
2 EXHIBIT 31.1 ex_142393.htm EX-31.1 16064
3 EXHIBIT 31.2 ex_142394.htm EX-31.2 16871
4 EXHIBIT 32.1 ex_142395.htm EX-32.1 11684
11 ex_142393img001.jpg GRAPHIC 2964
12 ex_142393img002.gif GRAPHIC 4887
  Complete submission text file 0001437749-19-009360.txt   3073841

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT plxp-20190331.xml EX-101.INS 451911
6 XBRL TAXONOMY EXTENSION SCHEMA plxp-20190331.xsd EX-101.SCH 31079
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20190331_cal.xml EX-101.CAL 31733
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20190331_def.xml EX-101.DEF 255485
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20190331_lab.xml EX-101.LAB 258253
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20190331_pre.xml EX-101.PRE 272194
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 19812857
SIC: 2834 Pharmaceutical Preparations